Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis
Ovarian cancer (OC) is prone to peritoneum or omentum dissemination, thus giving rise to the formidable challenge of unresectable surgery and a dismal survival rate. Although niraparib holds a pivotal role in the maintenance treatment of OC, its effect on suppressing metastases during primary interv...
Saved in:
Main Authors: | Ning Jin, Yi-yu Qian, Xiao-fei Jiao, Zhen Wang, Xin Li, Wen Pan, Jin-kai Jiang, Pu Huang, Si-yuan Wang, Ping Jin, Qing-lei Gao, Dan Liu, Yu Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725000412 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perspectives of pressurized intraperitoneal aerosol chemotherapy in terms of primary ovarian cancer with peritoneal carcinomatosis treatment
by: A. S. Dzasokhov, et al.
Published: (2023-03-01) -
Post-operative Analgesia with Intraperitoneal Bupivacaine Alone and with Dexmedetomidine Following Laparoscopic Cholecystectomy
by: Anees Ahmad, et al.
Published: (2025-01-01) -
Intraperitoneal Steroid Therapy for Recurrent Malignant Ascites in Advanced Cancer Patients: A Case Series
by: Nashid Islam, et al.
Published: (2025-01-01) -
Metabolic consequences of erastin-induced ferroptosis in human ovarian cancer cells: an untargeted metabolomics study
by: Kaylie I. Kirkwood-Donelson, et al.
Published: (2025-01-01) -
Case report: Conservative treatment of an intraperitoneal bladder rupture
by: Noah J. Sandel, et al.
Published: (2025-03-01)